Reducing heart dose during left breast cancer radiotherapy: comparison among 3 radiation techniques

Tumori
Giuseppe R D'AgostinoVincenzo Valentini

Abstract

Breast cancer survivors have a high risk of cardiac death as a consequence of heart irradiation during left breast tangential radiotherapy (RT). This study compares the cardiac dose delivered by standard 3D conformal tangential RT (CRT) to that delivered by prospective-gating RT (PGRT) or 5-field intensity-modulated RT (IMRT). Patients with early left breast cancer, referred for adjuvant RT to our institution, were enrolled in this study. For each patient, 2 simulation computed tomography scans were acquired: the first during free breathing, and the second on prospective gating during deep inspiration breath-hold. The scans were monitored by the Varian RPM™ respiratory gating system. For each patient, 3 treatment plans were performed: a 3D-CRT and an IMRT plan, each based on the free-breathing scan, and a PGRT plan, based on the deep inspiration breath-hold scan. Dose-volume histograms were compared by means of the Friedman test. The median mean heart dose was 3 Gy (range 0.9-7.3 Gy) in the CRT plans, 1.9 Gy (range 0.5-3.6 Gy) in the PGRT plans, and 4.5 Gy (range 1.1-10.5 Gy) in the IMRT plans (p = 0.001). The mean heart V25 was 1.2% (range 0%-9.7%), 0% (range 0%-2.0%), and 0.2% (range 0%-7.3%) for CRT, PGRT, and IMRT plans, re...Continue Reading

References

Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·L E RutqvistH Johansson
Apr 29, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A J NixonJ R Harris
Feb 8, 2000·International Journal of Radiation Oncology, Biology, Physics·G GagliardiL E Rutqvist
Mar 15, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T J WhelanM L Levine
Apr 9, 2002·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·B C John ChoBen J Mijnheer
Apr 9, 2002·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Coen W HurkmansBen J Mijnheer
Feb 8, 2003·International Journal of Radiation Oncology, Biology, Physics·Antony J LomaxRaymond Miralbell
Jun 28, 2003·International Journal of Radiation Oncology, Biology, Physics·Editha A KruegerLori J Pierce
Jul 9, 2004·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Anders N PedersenLena Specht
Sep 13, 2005·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Stine S KorremanHåkan Nyström
Apr 19, 2006·International Journal of Radiation Oncology, Biology, Physics·Eric J Hall
Jun 6, 2006·International Journal of Radiation Oncology, Biology, Physics·Stine S KorremanHåkan Nyström
Dec 30, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paul A HeidenreichSteven L Hancock
Jul 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Candace R CorreaEleanor E Harris
Sep 25, 2007·International Journal of Radiation Oncology, Biology, Physics·Wayne A BeckhamIvo A Olivotto
Feb 21, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jean-Philippe PignolLawrence Paszat
Nov 18, 2008·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Alessio G MorgantiGiovanni Scambia
Feb 18, 2010·International Journal of Radiation Oncology, Biology, Physics·Sarah C DarbyRoy E Shore
Feb 19, 2010·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Brigitte ZurlKarin Sigrid Kapp
Mar 5, 2010·International Journal of Radiation Oncology, Biology, Physics·Lawrence B MarksJoseph O Deasy
Mar 5, 2010·International Journal of Radiation Oncology, Biology, Physics·Giovanna GagliardiLawrence B Marks
Apr 28, 2010·International Journal of Radiation Oncology, Biology, Physics·Mary FengLori J Pierce
May 21, 2010·Physics in Medicine and Biology·Giorgia NicoliniLuca Cozzi
Mar 7, 2012·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Angela SardaroMaurizio Portaluri
Apr 12, 2012·Cancer Investigation·Philippe GiraudUNKNOWN Stic Study Centers
Jan 22, 2013·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Mar 15, 2013·The New England Journal of Medicine·Sarah C DarbyPer Hall
Jul 31, 2013·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Ebbe L LorenzenCarsten Brink
Jul 25, 2015·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·A FiorentinoF Alongi

❮ Previous
Next ❯

Citations

Sep 12, 2016·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·A CabanneS Rivera
Mar 2, 2018·Expert Opinion on Pharmacotherapy·Nathalie DonisPatrizio Lancellotti

❮ Previous
Next ❯

Methods Mentioned

BETA
irradiating

Software Mentioned

Varian Real - time Position Management (
Eclipse
Varian
Medcalc

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.